Not applicableStudy completedNCT05632484
What this trial is testing
Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia
Who this might be right for
Hereditary Haemorrhagic Telangiectasia
Hospices Civils de Lyon 16